These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18577547)

  • 21. Delay discounting of reward and caudate nucleus volume in individuals with α-synuclein gene duplication before and after the development of Parkinson's disease.
    Szamosi A; Nagy H; Kéri S
    Neurodegener Dis; 2013; 11(2):72-8. PubMed ID: 23038403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
    Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.
    Shiner T; Seymour B; Wunderlich K; Hill C; Bhatia KP; Dayan P; Dolan RJ
    Brain; 2012 Jun; 135(Pt 6):1871-83. PubMed ID: 22508958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P; Schwartz G; Masson M; Kann S; Volkow ND; Li CR; Leung HC
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
    Hirano S
    Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease.
    Simioni AC; Dagher A; Fellows LK
    Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. It's all in the type of the task: Dopamine modulates kinematic patterns during competitive vs. cooperative interaction in Parkinson's disease.
    Straulino E; Scaravilli T; Bulgheroni M; D'Amico E; Castiello U
    Neuropsychologia; 2016 Dec; 93(Pt A):106-115. PubMed ID: 27756693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.
    van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR
    Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reward processing dysfunction in ventral striatum and orbitofrontal cortex in Parkinson's disease.
    du Plessis S; Bossert M; Vink M; van den Heuvel L; Bardien S; Emsley R; Buckle C; Seedat S; Carr J
    Parkinsonism Relat Disord; 2018 Mar; 48():82-88. PubMed ID: 29307561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
    Sawamoto N; Piccini P; Hotton G; Pavese N; Thielemans K; Brooks DJ
    Brain; 2008 May; 131(Pt 5):1294-302. PubMed ID: 18362097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?
    Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R
    Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of dopamine in the brain - lessons learned from Parkinson's disease.
    Meder D; Herz DM; Rowe JB; Lehéricy S; Siebner HR
    Neuroimage; 2019 Apr; 190():79-93. PubMed ID: 30465864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential influence of levodopa on reward-based learning in Parkinson's disease.
    Graef S; Biele G; Krugel LK; Marzinzik F; Wahl M; Wotka J; Klostermann F; Heekeren HR
    Front Hum Neurosci; 2010; 4():169. PubMed ID: 21048900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional imaging of cognition in Parkinson's disease.
    Carbon M; Marié RM
    Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor loop dysfunction causes impaired cognitive sequencing in patients suffering from Parkinson's disease.
    Schönberger AR; Hagelweide K; Pelzer EA; Fink GR; Schubotz RI
    Neuropsychologia; 2015 Oct; 77():409-20. PubMed ID: 26382750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.